Because digestion is slowed, it is common for Wegovy to affect the stomach and bowels, especially during the early stages of treatment
Its human safety profile is not established there is no completed human trial
After these procedures, the cells were washed, the medium was replaced with extracellular saline solution, and the cells were imaged by fluorescence microscopy (Nikon, Eclipse TS2000, Tokyo, Japan)
Such bacterial growth leads to urinary tract infections and recurrent UTIs in diabetics
These findings suggest that the pharmacokinetic disadvantages of natural products can be partially compensated by pharmaceutical technologies, yet systematic studies are still required to determine whether they can achieve clinical applicability comparable to standard therapies